Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
or

Betterlife Pharma Inc (BETR.CN)

Betterlife Pharma Inc (BETR.CN)
0.0850 x 50000 0.1000 x 78000
Post-market by (Cboe BZX)
0.0950 +0.0050 (+5.56%) 03/14/25 [CNSX]
0.0850 x 50000 0.1000 x 78000
Post-market 0.0950 unch (unch) 15:40 ET
Quote Overview for Fri, Mar 14th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
0.0950
Day High
0.0950
Open 0.0950
Previous Close 0.0900 0.0900
Volume 29,000 29,000
Avg Vol 82,190 82,190
Stochastic %K 33.33% 33.33%
Weighted Alpha -39.19 -39.19
5-Day Change +0.0050 (+5.56%) +0.0050 (+5.56%)
52-Week Range 0.0800 - 0.1950 0.0800 - 0.1950
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure

Fundamentals

See More
  • Market Capitalization, $K 12,309
  • Shares Outstanding, K 129,573
  • Annual Sales, $ 0 K
  • Annual Income, $ -2,889 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 0.83
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.03
  • Most Recent Earnings $0.00 on 12/31/24
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sector N/A
  • INDUSTRY GROUPING:

    SIC-2834 Pharmaceutical Preparations

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0800 +18.75%
on 03/11/25
Period Open: 0.1150
0.1150 -17.39%
on 02/19/25
-0.0200 (-17.39%)
since 02/14/25
3-Month
0.0800 +18.75%
on 03/11/25
Period Open: 0.1100
0.1750 -45.71%
on 01/23/25
-0.0150 (-13.64%)
since 12/13/24
52-Week
0.0800 +18.75%
on 03/11/25
Period Open: 0.1000
0.1950 -51.28%
on 08/28/24
-0.0050 (-5.00%)
since 03/14/24

Most Recent Stories

More News
BetterLife Announces Debt Conversions

BETR.CN : 0.0950 (+5.56%)
BETRF : 0.0711 (+6.92%)
USPTO Grants BetterLife’s BETR-001 Composition of Matter Patent

BETR.CN : 0.0950 (+5.56%)
BETRF : 0.0711 (+6.92%)
BetterLife Announces Favorable Outcome in New York Legal Claims

BETR.CN : 0.0950 (+5.56%)
BETRF : 0.0711 (+6.92%)
BetterLife Obtains Favourable Cardiac Safety Data for BETR-001

BETR.CN : 0.0950 (+5.56%)
BETRF : 0.0711 (+6.92%)
BetterLife Obtains Favourable Genotoxicity Data for Oral BETR-001

BETR.CN : 0.0950 (+5.56%)
BETRF : 0.0711 (+6.92%)
BetterLife Pharma Inc. to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference

Vancouver, British Columbia--(Newsfile Corp. - April 15, 2024) - BetterLife Pharma Inc. (CSE: BETR) (OTCQB: BETRF), an emerging biotech company focused on the development and commercialization of cutting-edge...

BETRF : 0.0711 (+6.92%)
BETR.CN : 0.0950 (+5.56%)
BetterLife Pharma to Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference

Vancouver, British Columbia--(Newsfile Corp. - April 24, 2023) - BetterLife Pharma (CSE: BETR), an emerging biotech company focused on the development and commercialization of cutting-edge treatments for...

BETRF : 0.0711 (+6.92%)
BETR.CN : 0.0950 (+5.56%)
BetterLife To Participate at the H.C. Wainwright 1st Annual Mental Health Conference

VANCOUVER, British Columbia, June 23, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA:...

BETR.CN : 0.0950 (+5.56%)
BETRF : 0.0711 (+6.92%)
BetterLife To Present BETR-001 Preclinical Data at the Upcoming Canadian Association for Neuroscience Conference

VANCOUVER, British Columbia, April 21, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA:...

BETR.CN : 0.0950 (+5.56%)
BETRF : 0.0711 (+6.92%)
BetterLife Obtains In Vivo PK Data for BETR-001 Confirming its Bioavailability in Brain

VANCOUVER, British Columbia, March 16, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA:...

BETR.CN : 0.0950 (+5.56%)
BETRF : 0.0711 (+6.92%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

BetterLife Pharma Inc a biotechnology company, engages in the development and commercialization of psychedelic products for the treatment of mental disorders in Canada, the United States, Australia, and the European Union. It is involved in refining and developing drug candidates from a set of complementary...

See More

Key Turning Points

3rd Resistance Point 0.0950
2nd Resistance Point 0.0950
1st Resistance Point 0.0950
Last Price 0.0950
1st Support Level 0.0950
2nd Support Level 0.0950
3rd Support Level 0.0950

See More

52-Week High 0.1950
Fibonacci 61.8% 0.1511
Fibonacci 50% 0.1375
Fibonacci 38.2% 0.1239
Last Price 0.0950
52-Week Low 0.0800

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Precision Trading with Bollinger Bands: Identifying Breakouts & Reversals